These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2248741)

  • 1. Localized antigen challenge of the nasal mucosa.
    Flowers BK; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1990 Dec; 116(12):1407-10. PubMed ID: 2248741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-provoked increase in histamine reactivity. Observations on mechanisms.
    Walden SM; Proud D; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):642-8. PubMed ID: 1892305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a single-dose pretreatment with captopril on the immediate response to nasal challenge with allergen.
    Proud D; Naclerio RM; Meyers DA; Kagey-Sobotka A; Lichtenstein LM; Valentine MD
    Int Arch Allergy Appl Immunol; 1990; 93(2-3):165-70. PubMed ID: 1965981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
    Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
    Majchel AM; Proud D; Freidhoff L; Creticos PS; Norman PS; Naclerio RM
    J Allergy Clin Immunol; 1992 Jul; 90(1):85-91. PubMed ID: 1629510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to ragweed-pollen nasal challenge before and after immunotherapy.
    Creticos PS; Marsh DG; Proud D; Kagey-Sobotka A; Adkinson NF; Friedhoff L; Naclerio RM; Lichtenstein LM; Norman PS
    J Allergy Clin Immunol; 1989 Aug; 84(2):197-205. PubMed ID: 2668381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity.
    Juliusson S; Holmberg K; Baumgarten CR; Olsson M; Enander I; Pipkorn U
    Allergy; 1991 Aug; 46(6):459-65. PubMed ID: 1957995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline reduces histamine release during pollen-induced rhinitis.
    Naclerio RM; Bartenfelder D; Proud D; Togias AG; Meyers DA; Kagey-Sobotka A; Norman PS; Lichtenstein LM
    J Allergy Clin Immunol; 1986 Nov; 78(5 Pt 1):874-6. PubMed ID: 2431021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
    Creticos PS; Adkinson NF; Kagey-Sobotka A; Proud D; Meier HL; Naclerio RM; Lichtenstein LM; Norman PS
    J Clin Invest; 1985 Dec; 76(6):2247-53. PubMed ID: 2416777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
    Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
    Pipkorn U; Proud D; Lichtenstein LM; Schleimer RP; Peters SP; Adkinson NF; Kagey-Sobotka A; Norman PS; Naclerio RM
    J Clin Invest; 1987 Oct; 80(4):957-61. PubMed ID: 2443539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions.
    Greiff L; Pipkorn U; Alkner U; Persson CG
    Clin Exp Allergy; 1990 May; 20(3):253-9. PubMed ID: 2364306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediator release after nasal airway challenge with allergen.
    Naclerio RM; Meier HL; Kagey-Sobotka A; Adkinson NF; Meyers DA; Norman PS; Lichtenstein LM
    Am Rev Respir Dis; 1983 Oct; 128(4):597-602. PubMed ID: 6354022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis].
    Tahamiler R; Saritzali G; Canakçioğlu S
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):30-6. PubMed ID: 17483609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients.
    Mosimann BL; White MV; Hohman RJ; Goldrich MS; Kaulbach HC; Kaliner MA
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):95-104. PubMed ID: 7687608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines.
    Bensch GW; Nelson HS; Borish LC
    Ann Allergy Asthma Immunol; 2002 May; 88(5):457-62. PubMed ID: 12027065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.
    Baumgarten CR; Nichols RC; Naclerio RM; Lichtenstein LM; Norman PS; Proud D
    J Immunol; 1986 Aug; 137(3):977-82. PubMed ID: 3522740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory mediators in late antigen-induced rhinitis.
    Naclerio RM; Proud D; Togias AG; Adkinson NF; Meyers DA; Kagey-Sobotka A; Plaut M; Norman PS; Lichtenstein LM
    N Engl J Med; 1985 Jul; 313(2):65-70. PubMed ID: 2582257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.
    Togias AG; Naclerio RM; Proud D; Fish JE; Adkinson NF; Kagey-Sobotka A; Norman PS; Lichtenstein LM
    J Clin Invest; 1985 Oct; 76(4):1375-81. PubMed ID: 2414318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.